Targeting Antigen to Mouse Dendritic Cells via Clec9A Induces Potent CD4 T Cell Responses Biased toward a Follicular Helper Phenotype

被引:187
作者
Lahoud, Mireille H. [1 ,2 ]
Ahmet, Fatma [1 ]
Kitsoulis, Susie [1 ]
Wan, Soo San [1 ]
Vremec, David [1 ]
Lee, Chin-Nien [1 ]
Phipson, Belinda [1 ]
Shi, Wei [1 ,2 ,3 ]
Smyth, Gordon K. [1 ]
Lew, Andrew M. [1 ]
Kato, Yu [4 ]
Mueller, Scott N. [4 ]
Davey, Gayle M. [4 ]
Heath, William R. [4 ]
Shortman, Ken [1 ,2 ]
Caminschi, Irina [1 ,4 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia
[3] Univ Melbourne, Dept Comp Sci & Software Engn, Melbourne, Vic 3010, Australia
[4] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia
基金
英国医学研究理事会;
关键词
C-TYPE LECTIN; IMMUNE-RESPONSES; IN-VIVO; ANTIBODY-RESPONSES; CROSS-PRESENTATION; SUBSET; ACTIVATION; EXPRESSION; EFFICIENT; DEC-205;
D O I
10.4049/jimmunol.1101176
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Three surface molecules of mouse CD8(+) dendritic cells (DCs), also found on the equivalent human DC subpopulation, were compared as targets for Ab-mediated delivery of Ags, a developing strategy for vaccination. For the production of cytotoxic T cells, DEC-205 and Clec9A, but not Clec12A, were effective targets, although only in the presence of adjuvants. For Ab production, however, Clec9A excelled as a target, even in the absence of adjuvant. Potent humoral immunity was a result of the highly specific expression of Clec9A on DCs, which allowed longer residence of targeting Abs in the bloodstream, prolonged DC Ag presentation, and extended CD4 T cell proliferation, all of which drove highly efficient development of follicular helper T cells. Because Clec9A shows a similar expression pattern on human DCs, it has particular promise as a target for vaccines of human application. The Journal of Immunology, 2011, 187: 842-850.
引用
收藏
页码:842 / 850
页数:9
相关论文
共 40 条
[1]   Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells [J].
Bachem, Annabell ;
Guettler, Steffen ;
Hartung, Evelyn ;
Ebstein, Frederic ;
Schaefer, Michael ;
Tannert, Astrid ;
Salama, Abdulgabar ;
Movassaghi, Kamran ;
Opitz, Corinna ;
Mages, Hans W. ;
Henn, Volker ;
Kloetzel, Peter-Michael ;
Gurka, Stephanie ;
Kroczek, Richard A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (06) :1273-1281
[2]   The strategy of T cell antigen-presenting cell encounter in antigen-draining lymph nodes revealed by imaging of initial T cell activation [J].
Bajénoff, M ;
Granjeaud, S ;
Guerder, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (05) :715-724
[3]   Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance [J].
Bonifaz, L ;
Bonnyay, D ;
Mahnke, K ;
Rivera, M ;
Nussenzweig, MC ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) :1627-1638
[4]   In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination [J].
Bonifaz, LC ;
Bonnyay, DP ;
Charalambous, A ;
Darguste, DI ;
Fujii, SI ;
Soares, H ;
Brimnes, MK ;
Moltedo, B ;
Moran, TM ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (06) :815-824
[5]   Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses [J].
Boscardin, SB ;
Hafalla, JCR ;
Masilamani, RF ;
Kamphorst, AO ;
Zebroski, HA ;
Rai, U ;
Morrot, A ;
Zavala, F ;
Steinman, RM ;
Nussenzweig, RS ;
Nussenzweig, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (03) :599-606
[6]   The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement [J].
Caminschi, Irina ;
Proietto, Anna I. ;
Ahmet, Fatma ;
Kitsoulis, Susie ;
Teh, Joo Shin ;
Lo, Jennifer C. Y. ;
Rizzitelli, Alexandra ;
Wu, Li ;
Vremec, David ;
van Dommelen, Serani L. H. ;
Campbell, Ian K. ;
Maraskovsky, Eugene ;
Braley, Hal ;
Davey, Gayle M. ;
Mottram, Patricia ;
De Velde, Nicholas van ;
Jensen, Kent ;
Lew, Andrew M. ;
Wright, Mark D. ;
Heath, William R. ;
Shortman, Ken ;
Lahoud, Mireille H. .
BLOOD, 2008, 112 (08) :3264-3273
[7]   Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells [J].
Caminschi, Irina ;
Ahmet, Fatma ;
Heger, Klaus ;
Brady, Jason ;
Nutt, Stephen L. ;
Vremec, David ;
Pietersz, Suzanne ;
Lahoud, Mireille H. ;
Eld, Louis Schofi ;
Hansen, Diana S. ;
O'Keeffe, Meredith ;
Smyth, Mark J. ;
Bedoui, Sammy ;
Davey, Gayle M. ;
Villadangos, Jose A. ;
Heath, William R. ;
Shortman, Ken .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (11) :2579-2590
[8]   Enhancing immune responses by targeting antigen to DC [J].
Caminschi, Irina ;
Lahoud, Mireille H. ;
Shortman, Ken .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (04) :931-938
[9]   CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses [J].
Castro, Fernanda V. V. ;
Tutt, Alison L. ;
White, Ann L. ;
Teeling, Jessica L. ;
James, Sonya ;
French, Ruth R. ;
Glennie, Martin J. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (08) :2263-2273
[10]   Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin [J].
Charalambous, Anna ;
Oks, Margarita ;
Nchinda, Godwin ;
Yamazaki, Sayuri ;
Steinman, Ralph M. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (12) :8410-8421